Compare Digital Realty Trust, Inc. (DLR) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Digital Realty Trust, Inc. vs GSK plc — how do they compare? Digital Realty Trust, Inc. trades at $191.45 (market cap $70.79B), while GSK plc trades at $50.58 (market cap $104.15B). The key difference: GSK plc is the larger of the two by market cap, and GSK plc pays the higher dividend (3.48%). Which is the better fit depends on your goals.
| DLR | GSK | |
|---|---|---|
Market Cap | $70.79B | $104.15B |
Sector | Real Estate | Health |
52-Week High | $203.91 | $61.18 |
52-Week Low | $147.93 | $38.22 |
Enterprise Value | $89.50B | $124.56B |
Dividend Yield | 2.55% | 3.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
